The Importance of <i>STK11</i>/<i>LKB1</i> Assessment in Non-Small Cell Lung Carcinomas
Despite the recent implementation of immunotherapy as a single treatment or in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer (NSCLC), many patients do not benefit from this regimen due to primary treatment resistance or toxicity. Consequently, there is...
Main Authors: | Baharia Mograbi, Simon Heeke, Paul Hofman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/2/196 |
Similar Items
-
RhoBTB Proteins Regulate the Hippo Pathway by Antagonizing Ubiquitination of LKB1
by: Thanh Hung Nguyen, et al.
Published: (2020-04-01) -
Etude du rôle de LKB1 dans le foie
by: Just, Pierre-Alexandre
Published: (2014) -
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
by: Corrin A. Wohlhieter, et al.
Published: (2020-12-01) -
Negative Regulation of Serine Threonine Kinase 11 (STK11) through miR-100 in Head and Neck Cancer
by: Gabriela Figueroa-González, et al.
Published: (2020-09-01) -
Activating Mutations in <i>PTPN11</i> and <i>KRAS</i> in Canine Histiocytic Sarcomas
by: Marilia Takada, et al.
Published: (2019-07-01)